The estimated Net Worth of Lynette Herscha is at least $1.24 Milión dollars as of 27 July 2020. Ms. Herscha owns over 16,000 units of Solid Biosciences Inc stock worth over $1,243,340 and over the last 7 years she sold SLDB stock worth over $0. In addition, she makes $0 as Chief Legal Officer and Secretary at Solid Biosciences Inc.
Lynette has made over 1 trades of the Solid Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 16,000 units of SLDB stock worth $119,840 on 27 July 2020.
The largest trade she's ever made was exercising 16,000 units of Solid Biosciences Inc stock on 27 July 2020 worth over $119,840. On average, Lynette trades about 1,778 units every 0 days since 2017. As of 27 July 2020 she still owns at least 166,000 units of Solid Biosciences Inc stock.
You can see the complete history of Ms. Herscha stock trades at the bottom of the page.
Lynette Herscha is the Chief Legal Officer and Secretary of the Company since January 2019. Prior to joining us, she served as General Counsel, Secretary and a member of the Executive Team at Concert Pharmaceuticals, Inc., a public biopharmaceutical company, from 2017 to 2018 and its Vice President and Assistant Secretary Legal from 2014 to 2017. Before joining Concert Pharmaceuticals, Ms. Herscha held various senior legal positions at Momenta Pharmaceuticals, Inc., a public biotechnology company, from 2006 to 2014 and Phase Forward, Inc., a public technology company, from 2000 to 2006. She began her career at the law offices of Fullbright & Jaworski. Ms. Herscha holds a J.D. from Boston University School of Law and a B.A. from Boston University.
Lynette Herscha is 48, she's been the Chief Legal Officer and Secretary of Solid Biosciences Inc since 2019. There are 15 older and 7 younger executives at Solid Biosciences Inc. The oldest executive at Solid Biosciences Inc is Stephen J. DiPalma M.B.A., 62, who is the Treasurer & Principal Accounting Officer.
Lynette's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 141 PORTLAND ST., 5TH FLOOR, CAMBRIDGE, MA, 02139.
Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... a Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Solid Biosciences Inc executives and other stock owners filed with the SEC include: